In particular, DLK1 overexpression has been associated with increased aggressiveness and poor outcome in glioblastoma (GBM), hepatocellular carcinoma, ovarian, prostate, and lung cancer.11,47,49,50,90,92,93. Here, DLK1 is linked to glioblastoma.